Other Immunodeficient Mice/Rats_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen, drug development, antibody discovery

Product No	Product	Application area
210513	B-Il2rg KO rats	immunology, inflammation research, cancer research, xenograft/transplant host etc.
210512	B-SDG rats	immune system defections, virology research, inflammation research, cancer research, xenograft/transplant host etc
210511	B-Rag2 KO rats	immune system defections, virology research and cancer research etc
113288	B-hFcRn, Rag2 KO mice
112937	B-Rag2/Il2rg DKO mice
112259	B-hNKP46 mice(CB-17 SCID)
111654	B-Fcgr4 KO mice(CB-17 SCID)
112987	B-hCD16A/hNKP46 mice(CB-17 SCID)
112457	B-nude rats
110809	B-Rag2 KO mice	In the study of hematopoietic and immune system defects, cancer, toxicology and xenograft/transplant studies.

Biocytogen is headquartered in Beijing, with branches in Haimen, Jiangsu, Boston, Shanghai. Its wholly-owned subsidiary, Eucure Biopharma, focuses on clinical development.